EP Patent

EP3294337B1 — Treatment of debilitating fatigue by combined use of 3(s)-3-[3-(methylsulfonyl)phenyl]-1- propylpiperidine and an anti-depressive agent

Assigned to Arvid Carlsson Research AB · Expires 2024-12-18 · 1y expired

What this patent protects

Patent listed against Abilify.

Drugs covered by this patent

Patent Metadata

Patent number
EP3294337B1
Jurisdiction
EP
Classification
—
Expires
2024-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Arvid Carlsson Research AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.